The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment. / Petersen, Morten; Andersen, Jon T; Jimenez-Solem, Espen; Broedbaek, Kasper; Hjelvang, Brian R; Henriksen, Trine; Frandsen, Erik; Forman, Julie Lyng; Torp-Pedersen, Christian; Køber, Lars; Poulsen, Henrik Enghusen.

I: Clinical and Experimental Pharmacology and Physiology, Bind 39, Nr. 9, 09.2012, s. 779-785.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Petersen, M, Andersen, JT, Jimenez-Solem, E, Broedbaek, K, Hjelvang, BR, Henriksen, T, Frandsen, E, Forman, JL, Torp-Pedersen, C, Køber, L & Poulsen, HE 2012, 'The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment', Clinical and Experimental Pharmacology and Physiology, bind 39, nr. 9, s. 779-785. https://doi.org/10.1111/j.1440-1681.2012.05736.x

APA

Petersen, M., Andersen, J. T., Jimenez-Solem, E., Broedbaek, K., Hjelvang, B. R., Henriksen, T., Frandsen, E., Forman, J. L., Torp-Pedersen, C., Køber, L., & Poulsen, H. E. (2012). The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment. Clinical and Experimental Pharmacology and Physiology, 39(9), 779-785. https://doi.org/10.1111/j.1440-1681.2012.05736.x

Vancouver

Petersen M, Andersen JT, Jimenez-Solem E, Broedbaek K, Hjelvang BR, Henriksen T o.a. The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment. Clinical and Experimental Pharmacology and Physiology. 2012 sep.;39(9):779-785. https://doi.org/10.1111/j.1440-1681.2012.05736.x

Author

Petersen, Morten ; Andersen, Jon T ; Jimenez-Solem, Espen ; Broedbaek, Kasper ; Hjelvang, Brian R ; Henriksen, Trine ; Frandsen, Erik ; Forman, Julie Lyng ; Torp-Pedersen, Christian ; Køber, Lars ; Poulsen, Henrik Enghusen. / The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment. I: Clinical and Experimental Pharmacology and Physiology. 2012 ; Bind 39, Nr. 9. s. 779-785.

Bibtex

@article{ba409ef4979c4940819c4c6e439668f2,
title = "The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment",
abstract = "A gene-drug interaction has been indicated between beta-1 selective beta-blockers and the Arg389Gly polymorphism (rs1801253) in the adrenergic beta-1 receptor gene (ADRB1). We studied the effect of the ADRB1 Arg389Gly polymorphism on plasma renin activity (PRA) and heart rate (HR) and the genotype-dependent response to metoprolol and exercise. Twenty-nine healthy male subjects participated in 2 treatment periods (placebo and metoprolol). A 15-min submaximal exercise test was performed after each treatment period, and PRA and HR were measured before and after exercise. Before exercise, median PRA was lower in Gly/Gly subjects than in Arg/Arg subjects after both placebo (P = 0.030) and metoprolol treatment (P = 0.020). After placebo, the exercise-induced PRA increase was greater in Gly/Gly than in Arg/Gly and Arg/Arg subjects (P = 0.033). The linear association between log(PRA) and log(metoprolol concentration) varied significantly between genotypes (P = 0.024). In Gly/Gly subjects, PRA decreased significantly with metoprolol concentration before (P = 0.025) and after exercise (P <0.001), while in Arg/Gly and Arg/Arg metoprolol concentration had no effect on PRA. The effect of metoprolol concentration on PRA in Gly/Gly subjects was enhanced by exercise (P = 0.044). No significant differences in HR were seen between genotype groups. Resting PRA was lower in Gly/Gly than in Arg/Arg subjects, and the effect of exercise and metoprolol concentration on PRA was stronger in Gly/Gly subjects than with the other two genotypes. Gly/Gly heart failure patients might require lower doses of metoprolol than other patients to block neurohumoral hyperactivity. {\textcopyright} 2012 The Authors Clinical and Experimental Pharmacology and Physiology {\textcopyright} 2012 Blackwell Publishing Asia Pty Ltd.",
author = "Morten Petersen and Andersen, {Jon T} and Espen Jimenez-Solem and Kasper Broedbaek and Hjelvang, {Brian R} and Trine Henriksen and Erik Frandsen and Forman, {Julie Lyng} and Christian Torp-Pedersen and Lars K{\o}ber and Poulsen, {Henrik Enghusen}",
note = "{\textcopyright} 2012 The Authors Clinical and Experimental Pharmacology and Physiology {\textcopyright} 2012 Blackwell Publishing Asia Pty Ltd.",
year = "2012",
month = sep,
doi = "10.1111/j.1440-1681.2012.05736.x",
language = "English",
volume = "39",
pages = "779--785",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell Publishing Asia",
number = "9",

}

RIS

TY - JOUR

T1 - The Effect of the Arg389Gly Beta-1 Adrenoceptor Polymorphism on Plasma Renin Activity and Heart Rate and the Genotype-Dependent Response to Metoprolol Treatment

AU - Petersen, Morten

AU - Andersen, Jon T

AU - Jimenez-Solem, Espen

AU - Broedbaek, Kasper

AU - Hjelvang, Brian R

AU - Henriksen, Trine

AU - Frandsen, Erik

AU - Forman, Julie Lyng

AU - Torp-Pedersen, Christian

AU - Køber, Lars

AU - Poulsen, Henrik Enghusen

N1 - © 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd.

PY - 2012/9

Y1 - 2012/9

N2 - A gene-drug interaction has been indicated between beta-1 selective beta-blockers and the Arg389Gly polymorphism (rs1801253) in the adrenergic beta-1 receptor gene (ADRB1). We studied the effect of the ADRB1 Arg389Gly polymorphism on plasma renin activity (PRA) and heart rate (HR) and the genotype-dependent response to metoprolol and exercise. Twenty-nine healthy male subjects participated in 2 treatment periods (placebo and metoprolol). A 15-min submaximal exercise test was performed after each treatment period, and PRA and HR were measured before and after exercise. Before exercise, median PRA was lower in Gly/Gly subjects than in Arg/Arg subjects after both placebo (P = 0.030) and metoprolol treatment (P = 0.020). After placebo, the exercise-induced PRA increase was greater in Gly/Gly than in Arg/Gly and Arg/Arg subjects (P = 0.033). The linear association between log(PRA) and log(metoprolol concentration) varied significantly between genotypes (P = 0.024). In Gly/Gly subjects, PRA decreased significantly with metoprolol concentration before (P = 0.025) and after exercise (P <0.001), while in Arg/Gly and Arg/Arg metoprolol concentration had no effect on PRA. The effect of metoprolol concentration on PRA in Gly/Gly subjects was enhanced by exercise (P = 0.044). No significant differences in HR were seen between genotype groups. Resting PRA was lower in Gly/Gly than in Arg/Arg subjects, and the effect of exercise and metoprolol concentration on PRA was stronger in Gly/Gly subjects than with the other two genotypes. Gly/Gly heart failure patients might require lower doses of metoprolol than other patients to block neurohumoral hyperactivity. © 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd.

AB - A gene-drug interaction has been indicated between beta-1 selective beta-blockers and the Arg389Gly polymorphism (rs1801253) in the adrenergic beta-1 receptor gene (ADRB1). We studied the effect of the ADRB1 Arg389Gly polymorphism on plasma renin activity (PRA) and heart rate (HR) and the genotype-dependent response to metoprolol and exercise. Twenty-nine healthy male subjects participated in 2 treatment periods (placebo and metoprolol). A 15-min submaximal exercise test was performed after each treatment period, and PRA and HR were measured before and after exercise. Before exercise, median PRA was lower in Gly/Gly subjects than in Arg/Arg subjects after both placebo (P = 0.030) and metoprolol treatment (P = 0.020). After placebo, the exercise-induced PRA increase was greater in Gly/Gly than in Arg/Gly and Arg/Arg subjects (P = 0.033). The linear association between log(PRA) and log(metoprolol concentration) varied significantly between genotypes (P = 0.024). In Gly/Gly subjects, PRA decreased significantly with metoprolol concentration before (P = 0.025) and after exercise (P <0.001), while in Arg/Gly and Arg/Arg metoprolol concentration had no effect on PRA. The effect of metoprolol concentration on PRA in Gly/Gly subjects was enhanced by exercise (P = 0.044). No significant differences in HR were seen between genotype groups. Resting PRA was lower in Gly/Gly than in Arg/Arg subjects, and the effect of exercise and metoprolol concentration on PRA was stronger in Gly/Gly subjects than with the other two genotypes. Gly/Gly heart failure patients might require lower doses of metoprolol than other patients to block neurohumoral hyperactivity. © 2012 The Authors Clinical and Experimental Pharmacology and Physiology © 2012 Blackwell Publishing Asia Pty Ltd.

U2 - 10.1111/j.1440-1681.2012.05736.x

DO - 10.1111/j.1440-1681.2012.05736.x

M3 - Journal article

C2 - 22703382

VL - 39

SP - 779

EP - 785

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 9

ER -

ID: 40139856